Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Folic Acid Supplementation on the Presentation of Nuclear Abnormalities Associated With Cytogenotoxic Damage Induced by Chronic Drug Use.

NCT05712044 is registered in ClinicalTrials.gov with Centro Universitario de Tonalá as lead sponsor.

NCT NCT05712044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Folic Acid Supplementation on the Presentation of Nuclear Abnormalities Associated With Cytogenotoxic Damage Induced by Chronic Drug Use.
Lead sponsor
Centro Universitario de Tonalá
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2023
Completion date
August 1, 2023
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse, genotoxicity